Synovics Pharmaceuticals, Inc. Stock

Stocks

SYVC

US87163M1018

Pharmaceuticals

OTC Markets Traded
Real-time 11:02:23 2025-10-13 EDT 5-day change 1st Jan Change
0.000100 USD -50.00% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -
6 months+9,900.00%

Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.47M 1.35M 1.22M 2.3M 155M 2.35M 16.07M 6.46M 82.02M 6.16M 6.03M 260M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.26M 6.67M 6.06M 11.38M 770M 11.66M 79.63M 32.03M 406M 30.51M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day-50.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-.--%-.--% 3.65K
+0.58%+10.79%+58.42%+150.13% 1,257B
-1.08%-0.32%+43.82%+77.01% 651B
-0.01%+0.85%+36.26%+104.23% 510B
-1.56%-2.01%+50.67%+64.81% 388B
-2.46%+2.18%+75.67%+40.17% 366B
-0.02%+2.11%+32.16%+57.79% 303B
-0.72%+7.32%+11.29%+33.98% 288B
-0.37%+3.55%+56.55%+71.89% 252B
-0.96%+6.37%+38.65%+107.40% 211B
Average -5.64%+4.14%+40.35%+70.74% 422.67B
Weighted average by Cap. -0.48%+5.30%+48.08%+94.63%

Financials

2007 2008
Net sales 23.47M 20.96M 19.26M 17.49M 32.84M 2.22B 33.67M 230M 92.47M 1.17B 88.08M 86.2M 3.72B 25.96M 23.19M 21.3M 19.35M 36.33M 2.46B 37.25M 254M 102M 1.3B 97.44M 95.35M 4.11B
Net income -20.86M -18.63M -17.12M -15.55M -29.19M -1.98B -29.93M -204M -82.19M -1.04B -78.29M -76.62M -3.31B -4.01M -3.58M -3.29M -2.99M -5.61M -379M -5.75M -39.24M -15.79M -200M -15.04M -14.71M -635M
Net Debt 18.79M 16.79M 15.42M 14M 26.3M 1.78B 26.96M 184M 74.04M 939M 70.53M 69.02M 2.98B 6.49M 5.8M 5.32M 4.84M 9.08M 615M 9.31M 63.56M 25.57M 324M 24.35M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock